TREAT ON YOUR TERMS
.
CONSIDER CONVENIENCE WITH KESIMPTA
You can take it yourself, just once a month,* from the comfort of home—or take it with you. No infusion days required. Here are some other ways it can work with your busy life:
 | KESIMPTA comes to you:The pen is delivered right to your door—prefilled and ready to go when you are.† |
| It’s flexible with your schedule:Take it when and where works best for you‡ on treatment day. |
| It’s travel friendly:If you’re traveling on treatment day, don’t worry. The pen can be kept at room temp for up to 7 days,‡ so you can take it with you. |
*Once monthly after 3 weekly starter doses.
†Take the KESIMPTA pen out of the refrigerator 15 to 30 minutes before injecting to allow it to reach room temperature.
‡KESIMPTA pens must be refrigerated at 2 °C to 8 °C (36 °F to 46 °F). Keep product in the original carton to protect from light until the time of use. Do not freeze. To avoid foaming, do not shake. If stored below 86 °F (30 °C), unused KESIMPTA may be returned to the refrigerator and must be used within the next 7 days or discarded.
CHOOSING YOUR RMS TREATMENT
Each B-cell treatment comes with different requirements that can all factor into what your treatment day might look like.
Considerations in B-cell Treatments§
There are also different schedules and time frames to consider, along with how each treatment is taken.
Administration Times & Methods§
This is not a complete list of all the available treatments for RMS.§
The comparison pertains only to differences in dosing and administration and should not be considered a comparison of efficacy or safety.
§B-cell treatments for RMS include: KESIMPTA®, Ocrevus® (ocrelizumab), Ocrevus® Zunovo™ (ocrelizumab and hyaluronidase-ocsq), and Briumvi® (ublituximab-xiiy). Please see each product’s respective prescribing information for additional information, including indication, dosing, administration, and safety. Trademarks are the property of their respective owners.
‖Only limited benefit of premedication was observed in relapsing MS clinical studies.
¶Typical administration time when ready to inject.
#Once monthly after 3 weekly starter doses.
**The 1st infusion of Briumvi takes 4 hrs. Subsequent infusions take 1 hr.
Steps for Injecting KESIMPTA††
Someone from your health care team will give you guidance on how to take KESIMPTA for the first time, so you'll be ready on treatment day. When ready:
Remove from fridge 15-30 mins to get to room temp
Visually inspect for expiration date and liquid clarity
Choose and clean the injection site
Twist off cap only when ready to use. Discard cap, use within 5 mins
Press firmly against skin at 90º. After the second click, the green indicator will stop moving. Remove pen
Dispose in an FDA-cleared sharps container
Learn more about the KESIMPTA auto-injector pen and how to use it here.
††These are not the full Instructions for Use (IFU). Please see IFU for more information.
YOUR TREATMENT SCHEDULE
You’ll give yourself 1 dose per week for the first 3 weeks, and then you’ll skip a week. After that, you can move on to 1 dose per month.
3 Starter Doses
Pick a day and start with 1 dose a week for the first 3 weeks. Skip the 4th week.
1st Monthly Dose
Take your first monthly maintenance dose on the 5th week.
Maintenance Doses
Continue taking KESIMPTA once a month.
TRACKING TIP
To keep it simple, try to take KESIMPTA on the same date every month.
EXAMPLE: If your first monthly dose is on April 15, take your next dose on May 15.
How To Take KESIMPTA
This person has not taken KESIMPTA.
NEED HELP GETTING STARTED?
Count on personalized assistance at every step from Novartis Patient Support™ to answer questions and provide helpful resources.
MAGGIE S.
Mom, Recent Grad, and Real Patient
Switched to KESIMPTA: 2021
"I love having the flexibility to take KESIMPTA myself in the comfort of my own home. Unlike an infusion, I don't have to rearrange my work, family, or life just to get my treatment."
Up Next:
Hear what people who take KESIMPTA are saying.
Want more info to help you decide?
Find out why so many people are choosing KESIMPTA.
Prescribed KESIMPTA?
96% of all prescriptions filled paid as little as $0 out of pocket cost when used with the Co-Pay Plus offer.§||
RMS, relapsing multiple sclerosis.
§Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $18,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice. See complete Terms & Conditions at start.kesimpta.com.
||2025 data on file.